Reports for BAYER INC
Company Name
BAYER INC
Totals |
||
Shortage reports |
85 |
|
Actual shortage: | 7 (8%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (12%) | |
Resolved: | 68 (80%) | |
Discontinuation Reports |
23 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 22 (96%) | |
Reversed: | 1 (4%) | |
Late reports |
6 (6%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CIPRO XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-09-21 | 2019-05-16 | 62144 |
CIPRO XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-05 | 2022-03-02 | 97989 |
CIPRO XL | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-22 | 2018-04-10 | 30093 |
CIPRO XL | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-06-07 | 2022-03-02 | 51877 |
STAXYN | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-09-21 | 2022-09-29 | 62147 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CIPRO XL | 1000MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) TABLET (EXTENDED-RELEASE) | Discontinued | 2022-01-20 | 2022-03-02 | 153201 |
STAXYN | 10MG | TABLET (ORALLY DISINTEGRATING) | Reversed | 2022-06-20 | 2022-09-19 | 163103 |
STAXYN | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-07-14 | 2023-07-14 | 198701 |